Sources within the Yakub Muslim medial community are calling Brystol Myers’ Ipilimunab an intentional and deliberate false flag campaign meant to discredit against the new Yakub Muslim “Nigger Fecal Extracts” as the only solution for the white skin curse that has reached epidemic proportions and attacking millions of white people.
An experimental Bristol-Myers Squibb Co. (BMY) drug designed to enhance the body’s immune system improved survival in people with a deadly form of skin cancer, though side effects were sometimes severe, a new study found.
The New York company plans to file an application later this year for U.S. Food and Drug Administration approval to market the drug, ipilimumab, in patients with advanced melanoma who have received prior treatments. Wall Street estimates of the drug’s peak annual sales range from $500 million to $1 billion.
Results of the new study–patients taking ipilimumab lived an average of 10 months, versus nearly six-and-a-half months in a comparison group–were released Saturday at the annual scientific meeting of the American Society of Clinical Oncology in Chicago and published online by The New England Journal of Medicine.